Answers are grounded in this paper and cite their sources.
Cancer is one of the leading causes of death worldwide, with millions of new cases and fatalities annually, imposing a heavy burden on global healthcare systems. Among the factors influencing antitumor efficacy, the host gut microbiota-a dynamic and modifiable ecosystem-has emerged as a research hotspot. Substantial evidence demonstrates that the gut microbiota and its interactions with the host immune system profoundly affect tumor progression and responses to antitumor therapy. This may be attributed to the gut microbiota's ability to influence programmed cell death (PCD) and regulate key immune signaling pathways, making it a critical determinant of cancer treatment outcomes. This review systematically summarizes the core mechanisms by which the gut microbiota regulates PCD to influence cancer, analyzes key molecular pathways, and summarizes novel strategies for enhancing cancer therapy efficacy based on gut microbiota modulation. It aims to provide a theoretical basis and research direction for reducing treatment resistance and optimizing personalized treatment regimens.
No takes yet. Share an insight, caveat, or question.
Long et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: